• Molecular NameTrifluoperazine
  • SynonymTrifluoperazin; Trifluoperazina; Trifluoperazine Dihydrochloride; Trifluoperazine HCl; Trifluoperazine Hydrochloride; Trifluoromethylperazine; Trifluoroperazine; Trifluoroperazine Dihydrochloride; Trifluoroperazine Hydrochloride; Trifluperazine; Trifluroperizine; Triphthazine Dihydrochloride; Tryptazine Dihydrochloride
  • Weight407.504
  • Drugbank_IDDB00831
  • ACS_NO117-89-5
  • Show 2D model
  • LogP (experiment)5.0
  • LogP (predicted, AB/LogP v2.0)5.02
  • pka8.1 (24°)
  • LogD (pH=7, predicted)3.85
  • Solubility (experiment)0.0123 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-3.88
  • LogSw (predicted, AB/LogsW2.0)0.01
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors0
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds5
  • TPSA35.02
  • StatusFDA approved
  • AdministrationOral, IM
  • PharmacologyA typical antipsychotic drug of the phenothiazine group.
  • Absorption_value100.0
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life12 h
  • Excretion10–20 hours
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySymptoms of overdose include agitation, coma, convulsions, difficulty breathing, difficulty swallowing, dry mouth, extreme sleepiness, fever, intestinal blockage, irregular heart rate, low blood pressure, and restlessness.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A